Rebecca Cable

Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without Cirrhosis.

Background: Nonalcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver disease worldwide with tremendous clinical burden. The economic burden of NAFLD is not well studied. Goal: To assess the economic burden of NAFLD. Study: Medicare beneficiaries (January 1, 2010 to December 31, 2010) with NAFLD diagnosis by International Classification of Diseases, Ninth Revision codes in the absence of other liver diseases were selected. Inpatient and outpatient resource utilization parameters were total charges and total provider payments. NAFLD patients with compensated cirrhosis (CC) were compared with decompensated cirrhosis (DC). Results: A total of 976 inpatients and 4742 outpatients with NAFLD were included—87% were white, 36% male, 30% had cardiovascular disease (CVD) or metabolic syndrome conditions, and 12% had cirrhosis. For inpatients, median total hospital charge was

Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)

36,289. NAFLD patients with cirrhosis had higher charges and payments than noncirrhotic NAFLD patients (

368 Improvement of Patient-Reported Outcomes in Older Patients With Chronic Hepatitis C (CH-C) Treated With Interferon- and Ribavirin-Free Sofosbuvir (SOF)-Containing Regimens

61,151 vs.

Statin use is not associated with liver related mortality

33,863 and

Association of Sleep Disorders with Nonalcoholic Fatty Liver Disease (NAFLD): A Population-based Study

18,804 vs.

Tu1517 - Among Patients with Non-Alcoholic Fatty Liver Disease (NAFLD), Statins do not Reduce Cardiovascular or All-Cause Mortality

10,146, P<0.001). Compared with CC, NAFLD patients with DC had higher charges and payments (P<0.02). For outpatients, median total charge was

Psoriasis is Independently Associated with Non-Alcoholic Fatty Liver Disease

9,011. NAFLD patients with cirrhosis had higher charges and payments than noncirrhotic NAFLD patients (

Decreased Circulating Kynurenine is Associated with Post-Treatment Resolution of Fatigue as Measured by the FACIT-F in CH-C Patients

12,049 vs.

Mo1554 Contributors of Inpatient and Outpatient Resource Utilization for Medicare Beneficiaries With Non-Alcoholic Fatty Liver Disease and the Relation With Cirrhosis Status in 2010

8,830 and

230 Chronic Liver Disease (CLD) is Associated with Significant Health Care Expenditure in the United States (U.S.)

2,586 vs.